Simplex Trading, LLC Poseida Therapeutics, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$2.0 - $3.46 $2,670 - $4,619	1,335 New	1,335 $3,000
Q4 2023 Feb 02, 2024	BUY	$1.83 - $3.51 $12,056 - $23,123	6,588 New	6,588 $22,000
Q2 2023 Aug 04, 2023	SELL	$1.66 - $3.4 $751 - $1,540	-453 Reduced 74.26%	157 $0
Q1 2023 Apr 27, 2023	BUY	$3.08 - $8.73 $1,878 - $5,325	610 New	610 $1,000
Q2 2022 Aug 03, 2022	SELL	$1.87 - $5.0 $224 - $600	-120 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$3.22 - $7.04 $196 - $429	-61 Reduced 33.7%	120 $0
Q3 2021 Oct 28, 2021	BUY	$7.09 - $10.71 $709 - $1,071	100 Added 123.46%	181 $1,000
Q2 2021 Aug 12, 2021	BUY	$7.96 - $10.07 $644 - $815	81 New	81 $0
Q1 2021 Apr 26, 2021	SELL	$8.51 - $11.91 $851 - $1,191	-100 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$8.29 - $11.7 $828 - $1,170	100 New	100 $1,000

105

38.9M

451K

146K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.